Title

Chalazion Conservative Treatment Trial
A 5-year Multicenter Prospective Randomized Trial Comparing Three Conservative Chalazion Treatments
  • Phase

    N/A
  • Study Type

    Interventional
  • Intervention/Treatment

    tobramycin ...
  • Study Participants

    150
An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearing, pressure on the cornea, and irritation, all of which contribute to its morbidity. There are many anecdotal first line treatments for this condition, including warm compresses to the eyelid, topical antibiotics, topical steroids, topical combination antibiotic/steroid, and oral antibiotics. There have been no clinical trials to compare the efficacy of any of these conservative treatments. We wish to determine the most effective conservative medical treatment for chalazia.
Study Started
Nov 30
2010
Primary Completion
Jan 31
2016
Study Completion
Mar 31
2016
Results Posted
Jun 12
2018
Last Update
Jun 12
2018

Drug Hot Compress plus Tobramycin Drops and Ointment

In addition to hot compress, Tobramycin drops will be given to the affected eye 3x/day, and Tobramycin ointment will be given at night before bed.

  • Other names: Aktob, Tobralcon, Tobrasol, Tobramycin

Drug Hot compress plus Tobramycin/Dexamethasone Drops and Ointment

In addition to hot compress, Tobramycin/Dexamethasone drops will be given to the affected eye 3x/day, and Tobramycin/Dexamethasone ointment will be given at night before bed.

  • Other names: Tobramycin/dexamethasone

Other Hot Compresses

Hot compresses 3x/day to eyelids

Hot Compress Active Comparator

"Hot Compress"

Tobrex Active Comparator

"Hot Compress", "Tobrex Drops", "Tobrex Ointment"

Tobradex Active Comparator

"Hot Compress", "Tobradex Drops", "Tobradex Ointment"

Criteria

Inclusion Criteria

Patients age 18 and above
Patient with a palpable chalazion on any eyelid
Patients with multiple chalazia but only a single one on each lid
Normal lid anatomy enabling lid eversion

Exclusion Criteria

Patients with chalazia with atypical features (recurring chalazion, abnormal surrounding lid tissue, associated loss of lashes) that may indicate suspicion of malignancy
Patients allergic to any agents being used in the study (tobramycin, dexamethasone)
Patients who have had previous eyelid surgery to the same eyelid as the chalazion
Patients under 18 years of age
Patients without palpable lid chalazion
Patients with multiple chalazia on one eyelid
Patients with concurrent eyelid infection (cellulitis or conjunctivitis)
Patients unable to give consent

Summary

Hot Compress

Hot Compress, Tobrex Drops, Tobrex Ointment

Hot Compress, Tobradex Drops, Tobradex Ointment

All Events

Event Type Organ System Event Term

Number of Participants With Complete Resolution

Defined as number of patients with chalazion size regression of 100%

Hot Compress

13.0
participants

Hot Compress + Tobramycin Drops and Ointment

12.0
participants

Hot Compress + Tobramycin/Dexamethasone Drops and Ointment

11.0
participants

Chalazion Size Difference Post-Treatment

Change of size of eyelid chalazion in millimeters from baseline to 4-6 weeks post-treatment

Hot Compress

1.2
millimeters (Mean)
Standard Deviation: 3

Hot Compress + Tobramycin Drops and Ointment

1.69
millimeters (Mean)
Standard Deviation: 3

Hot Compress + Tobramycin/Dexamethasone Drops and Ointment

1.54
millimeters (Mean)
Standard Deviation: 3

Total

149
Participants

Age, Continuous

47.41
years (Mean)
Standard Deviation: 17

Initial lesion size (mm)

6.19
millimeters (Mean)
Standard Deviation: 3

Pre-treatment lesion duration (months)

3.96
months (Mean)
Standard Deviation: 8

Region of Enrollment

Sex: Female, Male

Overall Study

Hot Compress

Hot Compress + Tobramycin Drops and Ointment

Hot Compress + Tobramycin/Dexamethasone Drops and Ointment